We are live on ! Find out more
Ray Dalio

Ray Dalio Bridgewater Associates

AUM $22.4B
1-Year Est. Return 34.48%
 

Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.

This Fund
S&P 500
This Quarter Est. Return
-0.7%
1 Year Est. Return
+34.48%
3 Year Est. Return
+84.29%
5 Year Est. Return
+89.92%
10 Year Est. Return
+230.06%
AUM
$10.5B
AUM Growth
-$1.73B
Cap. Flow
-$1.74B
Cap. Flow %
-16.59%
Top 10 Hldgs %
73.24%
Holding
508
New
262
Increased
77
Reduced
116
Closed
48

Sector Composition

Rank Sector Weight
1 Healthcare 3.02%
2 Energy 2.11%
3 Consumer Discretionary 2.02%
4 Financials 1.95%
5 Consumer Staples 1.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHD icon
401
Church & Dwight Co
CHD
$24.5B
$426K ﹤0.01%
+8,460
New +$417K
MCHP icon
402
Microchip Technology
MCHP
$46B
$408K ﹤0.01%
8,924
-119,682
-93% -$5.51M
TSLA icon
403
Tesla
TSLA
$1.3T
$401K ﹤0.01%
22,605
CIEN icon
404
Ciena
CIEN
$58.4B
$396K ﹤0.01%
+15,294
New +$360K
JBL icon
405
Jabil
JBL
$35.8B
$395K ﹤0.01%
+13,745
New +$374K
SBSW icon
406
Sibanye-Stillwater
SBSW
$7.53B
$395K ﹤0.01%
102,910
+6,110
+6% +$26.5K
FLIR
407
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$394K ﹤0.01%
+7,871
New +$392K
NATI
408
DELISTED
National Instruments Corp
NATI
$392K ﹤0.01%
+7,749
New +$377K
MSFT icon
409
Microsoft
MSFT
$3.71T
$389K ﹤0.01%
+4,262
New +$390K
KN icon
410
Knowles
KN
$3.34B
$387K ﹤0.01%
+30,766
New +$448K
VSH icon
411
Vishay Intertechnology
VSH
$5.43B
$385K ﹤0.01%
+20,680
New +$414K
SPG icon
412
Simon Property Group
SPG
$72.3B
$376K ﹤0.01%
+2,437
New +$388K
EXPD icon
413
Expeditors International
EXPD
$23.2B
$374K ﹤0.01%
+5,915
New +$380K
AVX
414
DELISTED
AVX Corporation
AVX
$369K ﹤0.01%
+22,310
New +$394K
TEVA icon
415
Teva Pharmaceuticals
TEVA
$41.2B
$362K ﹤0.01%
21,200
-6,500
-23% -$127K
NOW icon
416
ServiceNow
NOW
$129B
$341K ﹤0.01%
10,315
ROL icon
417
Rollins
ROL
$18.2B
$336K ﹤0.01%
+14,801
New +$325K
LLL
418
DELISTED
L3 Technologies, Inc.
LLL
$333K ﹤0.01%
+1,600
New +$332K
CVSA
419
Covista Inc
CVSA
$4.8B
$331K ﹤0.01%
+6,957
New +$325K
BCO icon
420
Brink's
BCO
$4.62B
$330K ﹤0.01%
+4,622
New +$355K
ADI icon
421
Analog Devices
ADI
$190B
$329K ﹤0.01%
+3,614
New +$329K
CPRT icon
422
Copart
CPRT
$27.5B
$328K ﹤0.01%
+25,760
New +$298K
HRB icon
423
H&R Block
HRB
$5.86B
$327K ﹤0.01%
+12,862
New +$338K
VRSK icon
424
Verisk Analytics
VRSK
$25B
$327K ﹤0.01%
+3,149
New +$314K
RSG icon
425
Republic Services
RSG
$66B
$326K ﹤0.01%
+4,928
New +$330K

Similar funds

Ray Dalio's Q1 2018 Portfolio in Review

As of Q1 2018, Ray Dalio held 508 positions worth $10.5B, down 14% from $12.2B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Ray Dalio withdrew a net $1.74B in Q1 2018, closing 48 positions and reducing 116 holdings. Its most notable exit was Costco, an estimated $15.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3% of assets, up from 1.7% a quarter earlier, followed by Energy and Consumer Discretionary.

Against the trend, Ray Dalio opened a new position in Biogen worth $21.1M.

  • Ray Dalio's largest Q1 2018 buy was Biogen: 77,197 shares worth $21.1M.
  • Ray Dalio added most to Newfield Exploration in Q1 2018, an estimated $44.6M increase.
  • Ray Dalio's biggest Q1 2018 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $1.04B.
  • Ray Dalio fully exited Costco in Q1 2018, selling an estimated $15.6M.
  • Ray Dalio's ten largest holdings make up 73% of its $10.5B portfolio in Q1 2018.
  • Ray Dalio opened 262 new positions and closed 48 in Q1 2018.
  • Ray Dalio's portfolio value fell 14% quarter-over-quarter to $10.5B.

Based on Bridgewater Associates's 13F filing for Q1 2018, filed 15 May 2018.